Connect with us

Micro Cap Insider

Major Run on OZSC (Ozop Energy Solutions) PCTI Contracts & Electric Vehicle (EV) High Power Charging

Published

3 years ago

on

OZSC (Ozop Energy Solutions) is making powerhouse move up the charts in recent months skyrocketing out of the double zeroes to recent highs of $0.50 per share quickly gaining the attention of investors who have been heavily accumulating in recent days. OZSC has emerged as a serious powerhouse and volume leader in small caps trading 105 million shares and approximately $28 million in dollar volume on Friday alone. The stock started its move in early January and MIcrocapdaily was there reporting on the story. OZSC is making an enormous move as a new era of penny stock speculators fueled by robinhood and its 100 million new trading accounts take on the bulletin boards. These are different times than just a few short years ago; now penny stocks such as TSNP can achieve a $6 billion plus market valuation and trade $375 million in dollar volume in a day on the bulletin boards. And TSNP has no stronger fundamentals than OZSC has. OZSC has massive liquidity, legions of new shareholders and significant developments driving this powerhouse run.  

OZSC is trading like a winner; like a stock with limited paper in the float which comes after the Company reported it has repaid its legacy debt in full. The Company is making big moves in the booming EV space recently forming a partnership with Zeem Solutions to work on high power charging solutions to address the medium and heavy-duty commercial EV market. Zeem Solutions comprehensive packages include the e-vehicles, maintenance, charging, and overnight parking infrastructure for one monthly cost. According to McKinsey and Co, “by 2030, the US market for services to support the charging of electric vehicle fleets could be worth $15 billion. OZSC has been busy building up a powerhouse management team recently getting Ezra Green, Allen Sosis and Ian Graham to the Ozop Energy team represent another huge step towards developing Ozop Energy Systems into a global player of supply chain solutions within the renewable energy market. OZSC subsidiary PCTI is quickly becoming recognized on a global level with customers located throughout the world in Europe, Asia and the United States. PCTI customers include: US Army, US Navy, US Air Force, US Marines, Eaton, Delphi, Ford, Caterpillar, General Dynamics, Mitsubishi, General Moters, and NASA. PCTI has been biding on and securing some enormous projects for the US Military.  PCTI currently has at least 5 projects in production and others in various states in the queue with over $6.9 million in solid pipeline project.  

OZSC (Ozop Energy Solutions) invents, designs, develops, manufactures, and distributes ultra-high-power chargers, inverters, and power supplies for a wide variety of applications in the defense, heavy industrial, aircraft ground support, maritime and other sectors. Our strategy focuses on capturing a significant share of the rapidly growing renewable energy market as a provider of assets and infrastructure needed to store energy. Ozop Energy Systems is a leading Manufacturer and distributor of Renewable Energy products in the Energy Storage, Solar, Microgrids, and EV charging Station space. We are always among the first to receive the newest technology, products, and application techniques. We offer a broad portfolio of Renewable Energy products at competitive prices with a commitment to customer satisfaction from selection, to ordering, shipping, and delivery. 

The Company’s recently acquired subsidiary (Power Conversion Technologies Inc.) PCTI designs, develops and manufactures standard and custom power electronic solutions. PCTI is quickly bcoming recognized on a global level with customers located throughout the world in Europe, Asia and the United States and include general industrial customers, and military customers both domestically and internationally.  PCTI customers include: US Army, US Navy, US Air Force, US Marines, Eaton, Delphi, Ford, Caterpillar, General Dynamics, Mitsubishi, General Moters, and NASA. PCTI has been biding on and securing some enormous projects for the US Military and was recently the sole source bid to one of the world’s largest defense contractors for multiple power converter units to be used in naval automatic weapons systems. PCTI currently has at least 5 projects in production and others in various states in the queue with over $6.9 million in solid pipeline project. The Company is quickly gaining traction in the booming energy storage market, which Forbes estimates will grow from $59 billion in 2019 to $546 billion by 2035. PCTI products, technologies and expertise are a linchpin of this emerging industry.  

Microcapdaily has been covering OZSC since the stock was well below the $0.01 mark. In our previous look at the Company, we reported: “OZSC recently entered into a Master Supply Agreement with WESCO International, Inc. (NYSE: WCC). This agreement allows Ozop Energy Solutions, via its recently announced wholly owned subsidiary Ozop Energy Systems, access to premier manufacturers as a key source of top-quality products and solutions for the renewable energy market. Since 1922, WESCO has grown and transformed from a division of Westinghouse Electric into an industry-leading Fortune 500 supply chain solutions company. As the scale of energy storage projects increases globally, the Company’s relationship with WESCO creates an opportunity for providing one stop shopping for not only our clientele, but for the industry. 

On January 19 OZSC announced (PCTI) entered into a partnership with Zeem Solutions to work on high power charging solutions to address the medium and heavy-duty commercial EV market. Zeem Solutions is developing new and unique approaches to accelerate adoption in the commercial electric vehicle (CEV) fleet sector. They offer plug and play solutions for “last-mile delivery” which is the movement of people and/or goods from a transportation hub to a final destination. Their comprehensive packages include the e-vehicles, maintenance, charging, and overnight parking infrastructure for one monthly cost. According to McKinsey and Co, “by 2030, the US market for services to support the charging of electric vehicle fleets could be worth $15 billion.” 

Ozop has been busy in recent weeks; the Company announced an agreement with Bical Auto Mall, the largest dealership in the NY metropolitan area to purchase and resell EV chargers. The initial order is for 4 EV chargers for two locations (@ $80K) for Bical and we have executed a vendor agreement between the two companies so they can resell to the LMA, of which Mr. Bical is president, which is comprised of 300 additional dealerships in New York. Bical Auto Mall is the largest dealership in the metropolitan area that comprises of all four general motors brands that are Chevrolet, Buick, GMC, and Cadillac as well as a second store located in Valley Stream New York called “Bical Chevrolet” that comprises solely of Chevrolet.  

Investor Sentiment in OZSC is high:

https://twitter.com/likecheese2/status/1362882732171415553

To Find out the inside Scoop on OZSC Subscribe to Microcapdaily.com Right Now by entering your Email in the box below

OZSC

About PCTI (Power Conversion Technologies, Inc.)

The Company has been beefing up its management team recently adding Ezra Green as the new Director of Operations for its subsidiary Ozop Energy Systems, Inc. Mr. Green is an executive who was listed in the prestigious Franklin Report as one of the top 100 contractors in NYC and vicinity. Mr. Green also expanded his Company into the energy market, developing some of the most complex solar energy systems of the time. After developing these projects in California for several years, Mr. Green expanded operations to the east coast and eventually internationally to Larisa, Greece and Uttar Pradesh, India where he entered into an agreement with members of Parliament. Mr. Green has been the Chairman, CEO of several public technology companies and has been invited to sit on the boards of several emerging energy-tech related international organizations. In ther past Mr. Green has closed a $400 million contract for a Swiss wind development company. Mr. Green has been a repeat guest of the Fox Business channel, The Wall Street Journal, and multiple other media outlets. Mr. Green has several patents in wireless data communication for solar energy, autonomous guidance systems, energy sensors and charging systems.  

OZSC also recently appointed Mr. Allen Sosis as the new Director of Business Development for its subsidiary Ozop Energy Systems, Inc. Mr. Sosis has over 20 years in solar and renewable energy, ranging from all aspects of engineering, procurement, and construction on both the residential and commercial sides of the business. With a degree in economics, he spent 2 years as a minor league baseball player before venturing out into real estate, eventually crossing over into solar energy with Solar Tech, increasing sales by 200% in the first year. According to SING management, Mr. Allen is a walking Rolodex of contacts in renewable energy. Within his first week as a consultant, he established the Company’s supply chain and produced a pipeline showing $48 million in potential component sales for projects underway by a who’s who of energy companies 

On February 16, OZSC announced the hiring of Mr. Ian Graham as its new Consulting Engineer for its subsidiary Ozop Energy Systems, Inc. Ian Graham brings a long record of experience in microgrids, large scale wind, large scale solar, and battery storage. Mr. Graham has worked on some major projects including; Owners Engineer for Tesla 100MW project in California on the distribution system for Resource Adequacy. Design and owners engineer for CAISO blackstart 10MW battery. Development of merchant 200MW/400MWh standalone BESS project in Texas. Due diligence, design, and economics review for 20 standalone distributed BESS VDER projects in New York.Strata Solar: 100MW/400MWh battery project, 1MW/4MWh battery project, Design 20x 5-20MW projects for RFP solicitation and design, Evaluated 10+ PV sites for hybrid application. Element Energy Works: Feasibility + Design of 10MW Battery+CHP+Solar microgrid LA Basin. Owners Engineer blackstart BESS resource in CAISO 200MW. Development Engineering 3x 5MW BESS AC and DC coupled. Owners Engineer PV+BESS 20MWh. Development Engineering 80MW Wind+BESS Capacity value modeling, design and diligence. Alaska Wind Diesel Microgrid System, Size $7M. Duties were supplying a full turnkey project for the owners. 5MW Diesel modification, 2MW Wind injection, controls, SCADA and other resources for regulation. 

The additions of Ezra Green, Allen Sosis and Ian Graham to the Ozop Energy team represent another big step towards developing Ozop Energy Systems into a global player of supply chain solutions within the renewable energy market. 

For More on OZSF Subscribe Right Now!

OZSC is making powerhouse move up the charts in recent months skyrocketing out of the double zeroes to recent highs of $0.50 per share quickly gaining the attention of investors who have been heavily accumulating in recent days. OZSC has emerged as a serious powerhouse and volume leader in small caps trading 105 million shares and approximately $28 million in dollar volume on Friday alone. The stock started its move in early January and MIcrocapdaily was there reporting on the story when the stock was well under $0.01. OZSC is making an enormous move as a new era of penny stock speculators fueled by robinhood and its 100 million new trading accounts take on the bulletin boards. These are different times than just a few short years ago; now penny stocks such as TSNP can achieve a $6 billion plus market valuation and trade $375 million in dollar volume in a day on the bulletin boards. And TSNP has no stronger fundamentals than OZSC has. OZSC has massive liquidity, legions of new shareholders and significant developments driving this powerhouse run. OZSC is trading like a winner; like a stock with limited paper in the float which comes after the Company reported it has repaid its legacy debt in full. The Company is making big moves in the booming EV space recently forming a partnership with Zeem Solutions to work on high power charging solutions to address the medium and heavy-duty commercial EV market. Zeem Solutions comprehensive packages include the e-vehicles, maintenance, charging, and overnight parking infrastructure for one monthly cost. According to McKinsey and Co, “by 2030, the US market for services to support the charging of electric vehicle fleets could be worth $15 billion. OZSC has been busy building up a powerhouse management team recently getting Ezra Green, Allen Sosis and Ian Graham to the Ozop Energy team represent another huge step towards developing Ozop Energy Systems into a global player of supply chain solutions within the renewable energy market. OZSC subsidiary PCTI is quickly becoming recognized on a global level with customers located throughout the world in Europe, Asia and the United States. PCTI customers include: US Army, US Navy, US Air Force, US Marines, Eaton, Delphi, Ford, Caterpillar, General Dynamics, Mitsubishi, General Moters, and NASA. PCTI has been biding on and securing some enormous projects for the US Military.  PCTI currently has at least 5 projects in production and others in various states in the queue with over $6.9 million in solid pipeline project. We will be updating on OZSC when more details emerge so make sure you are subscribed to Microcapdaily so you know what’s going on with OZSC.

Subscribe to Our 100% Free Penny Stock Newsletter. We Have Something Big Coming!

Disclosure: we hold no position in OZSC either long or short and we have not been compensated for this article

Related Topics:
Continue Reading
1 Comment

1 Comment

  1. Steven Griffitts

    February 21, 2021 at 5:11 pm

    OZOP Energy Solutions is positioned for a strong presence within the Transition economy.

    Reply

Leave a Reply

Your email address will not be published. Required fields are marked *

Featured

IceCure Medical’s (NASDAQ: ICCM) ProSense: A 96.8% Success Rate Revolutionizing Breast Cancer Treatment

Published

20 mins ago

on

October 2, 2023

By

On October 2nd, 2023, IceCure Medical (NASDAQ: ICCM) shares surged by over 50% following exciting news presented at a major medical event, the European Society of Breast Imaging. Their cutting-edge ProSense® System, designed for minimally invasive cryoablation, is marketed and sold worldwide for its cleared indications in the U.S., Europe, and China. More recently they gained approvals in India, and Brazil and have additional distribution through MC Medical to continue expanding in Europe. More importantly, the latest independent study confirms that the technology is a safe & effective outpatient procedure for breast cancer, with 96.8% success rate.

More Background:

Their system has the potential to revolutionize cancer treatment not only for breast cancer, but also for kidney, bone, and lung cancers. To date, the system is marketed and sold worldwide for the indications cleared and approved to date including in the U.S., Europe, and China.

During the event, Dr. Lucía Graña-López, a radiologist specializing in breast and women’s imaging, led an independent study. The study explored cryoablation as a viable alternative to surgery for early-stage breast cancer in patients who preferred a non-surgical route. The results were promising, suggesting that cryoablation could be a successful treatment option, particularly for patients hesitant about traditional surgery.

Subscribe to Microcapdaily.com Right Now by entering your Email in the box below.

Subscribe to Our 100% Free Penny Stock Newsletter. We Have Something Big Coming!

Clinical Study:

The study involved 31 patients with early-stage breast cancer who opted out of surgery, and the outcomes showed that cryoablation was well-tolerated with no major complications. This alternative approach could potentially be a game-changer, especially for breast cancer, which is one of the most prevalent cancers globally. Many patients, particularly older individuals, are seeking less invasive alternatives to surgery, making cryoablation an appealing option.

Dr. Graña-López envisions cryoablation becoming a significant alternative to surgery, particularly for early-stage breast cancer in post-menopausal women. Moreover she believes this technology could reshape how we approach treatment in other indications, particularly for kidney, lung, and thyroid gland cancers.

These results from this independent study are are in line with the ongoing ICE3 study, the largest of its kind in the U.S., set to conclude in early 2024.

We will update you on ICCM when more details emerge, subscribe to Microcapdaily to follow along!

Subscribe to Our 100% Free Penny Stock Newsletter. We Have Something Big Coming!

Disclosure: We have not been compensated for this article/video. MicroCap Daily is not an investment advisor; this article/video does not provide investment advice. Always do your research, make your own investment decisions, or consult with your nearest financial advisor. This article/video is not a solicitation or recommendation to buy, sell, or hold securities. This article/video is our opinion, is meant for informational and educational purposes only, and does not provide investment advice. Past performance is not indicative of future performance.

Picture by marijana1 from Pixabay

Continue Reading

Featured

T2 Biosystems (NASDAQ: TTOO) Breaks Ground: FDA Clearance, Market Trends, and Healthcare Impact

Published

3 days ago

on

September 29, 2023

By

Shares of T2 Biosystems (NASDAQ:TTOO) are soaring up over 20% today on the heels of receiving a 510(k) clearance for its T2Biothreat from the FDA. This unique test directly detects six biothreat pathogens from a blood sample.

Spotting Biothreats Faster:

T2Biothreat Panel is a game-changer, being the first and only FDA-approved product that can spot these critical biothreat pathogens simultaneously. T2 Biosystems proudly stands as the first U.S. company to achieve this milestone, reshaping the field of biothreat detection.

Big Investor Sells:

Interestingly while celebrating this achievement, a significant investor, CR Group (CRG), decided to sell off a substantial chunk of shares. This sell-off, totaling 24.81 million shares, took place between Sept. 20 and Sept. 26. The timing of this sell-off alongside the FDA clearance raises some eyebrows.

Subscribe to Microcapdaily.com Right Now by entering your Email in the box below.

Subscribe to Our 100% Free Penny Stock Newsletter. We Have Something Big Coming!

New CDC Guidelines:

Regardless of CR Group selling, there still appears to be a massive opportunity according to many retail investors. Following new CDC guidelines, the U.S. government now mandates that all hospitals in the country must adopt rapid testing protocols to combat the sepsis pandemic by 2026, or risk losing Medicare funding.

Buying opportunity of the year!!! Update
byu/den1183 inTTOOstock

T2 Biosystems stands as the exclusive FDA-cleared product capable of achieving 100% accurate sepsis detection within 3 to 5 hours. Anticipating widespread adoption of T2 instruments in hospitals, the CEO foresees significant revenue generation, potentially reaching $1.3 billion annually, given the mandate.

This development drastically alters the landscape, potentially influencing the stock’s trajectory positively. With the ongoing surge in manufacturing hires and likely acceleration in orders, coupled with potential government contracts or international sales, many beleive T2 Biosystems presents an undervalued opportunity for investors.

What Borrowing Costs Tell Us:

Another interesting indicator to look at is the cost to borrow (CTB) fee. In terms of TTOO’s case, the stock has seen a massive surge in CTB fees, indicating a high demand from short sellers. When compared to the average CTB fee for other stocks, it’s pretty drastic. While this is typically not a very positive sign, retail investors seem to be buzzing with interest, given there also could be a potential short squeeze if enough buying comes in to trap the shorts.

Better News for Patients:

But let’s not forget the real impact and that’s what TTOO can do for patients. @ChengKeki a user from Twitter also shared an article about Butler Memorial Hospital and their approach to Sepsis. The hospital came up with a 2 step approach to expedite patient care.  They’re utilizing the Beckman Coulter automation line to identify changes in a person’s blood cells that might indicate the development of sepsis. Which apparently has only been used in Europe and they’re the first in the US with the technology. Then shortly after, they use T2 Biosystems panels that as you know, quicken the process from 36 hours, to just 3-5 hours.

Catching sepsis quickly is crucial because it’s a life-threatening condition that rapidly progresses throughout your body and can lead to death if not promptly diagnosed and treated. Sepsis occurs when the body responds improperly to an infection, causing widespread inflammation and potentially damages multiple organ systems. Early detection allows for immediate medical intervention.

Conclusion:

T2 Biosystems is hitting major milestones, not only in the market but in improving critical healthcare processes. The company is also a major hit with retail investors and continues to trade an astronomical amount of shares daily, the current average is ~115M shares. The FDA approval and its implications, along with the positive shift in sepsis diagnosis, showcase T2 Biosystems’ growing role in healthcare. Keep an eye on how this progresses—it’s exciting for both investors and patients alike.

We will update you on TTOO when more details emerge, subscribe to Microcapdaily to follow along!

Subscribe to Our 100% Free Penny Stock Newsletter. We Have Something Big Coming!

Picture by jarmoluk from Pixabay

 

Continue Reading

BioPharma

Organogenesis (NASDAQ: ORGO): Latest Developments and Future Growth Prospects

Published

4 days ago

on

September 28, 2023

By

Organogenesis Holdings (NASDAQ: ORGO), a top regenerative medicine company dedicated to advanced wound care, surgical, and sports medicine solutions, gains over 30% during intraday trading and after hours combined after their latest release. According to the release, three Medicare Administrative Contractors (MACs) decided to withdraw certain coverage rules that were meant to start on October 1. These rules related to products for treating diabetic foot ulcers (DFU) and venous leg ulcers (VLU).

More Background:

Organogenesis serves a range of clients, from hospitals and wound care centers to doctors’ offices. The MACs’ initial rules, set on August 9, caused concern. They specified that covered products must be particular types of skin substitutes. Unfortunately, this excluded five products from Organogenesis, impacting their financial outlook.

Fast forward, the MACs pulled back these rules just in time, preventing potential harm to Organogenesis. Even before these rules, the company was facing challenges. In the second quarter, revenue was slightly down compared to the same period last year. Despite this, the company is doing better than the previous year in a six-month comparison.

Subscribe to Microcapdaily.com Right Now by entering your Email in the box below.

Subscribe to Our 100% Free Penny Stock Newsletter. We Have Something Big Coming!

Gary S. Gillheeney, Sr., the head of Organogenesis, expressed deep gratitude for the MACs and the Centers for Medicare & Medicaid Services (CMS). He praised their thoughtful consideration of stakeholder concerns and putting patients first. This decision will positively affect the lives of many.

He also thanked the stakeholders, including doctors, patient advocacy groups, and various associations. Their unified support played a vital role in challenging these rules, considering the potential harm they could cause patients. Their advocacy shed light on the possible negative health outcomes and treatment disparities, especially for those with higher rates of diabetes and related conditions. Their collective efforts made a significant difference.

We will update you on ORGO when more details emerge, subscribe to Microcapdaily to follow along!

Subscribe to Our 100% Free Penny Stock Newsletter. We Have Something Big Coming!

Disclosure: We have not been compensated for this article/video. MicroCap Daily is not an investment advisor; this article/video does not provide investment advice. Always do your research, make your own investment decisions, or consult with your nearest financial advisor. This article/video is not a solicitation or recommendation to buy, sell, or hold securities. This article/video is our opinion, is meant for informational and educational purposes only, and does not provide investment advice. Past performance is not indicative of future performance.

Picture by Parentingupstream from Pixabay

Continue Reading

Trending

© All rights reserved.

Sign up now for our 100% FREE Penny Stock Newsletter

Privacy Policy. we will never share your email with anyone.